Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Simple you want? Bet you'll get at least three page long replies. It's all about eyeballs.
Yes! No dial in, no real transcript. Looking forward to it.
Lol.
It's the same kind of twisted optimism as over on Peregrind and others too, I'm sure. No acknowledgement that management has turned shareholders into donors, yet again. No cry out for heads to roll. "It's all about the science"
I clearly heard her say the trial will have a tough time getting FDA approval. A truly shocking comment for a blinded ongoing trial with public shareholders.
No it was not bogus. The London Times is a quality news source, this is not disputed by anyone but some here. Woodford likely didn't speak because he's involved in a suit. But through the author he did send a clear message of disgust with NWBO leadership, otherwise he would've spoken out against it, being a shareholder himself.
The idea that Powers&Co. don't know what the SEC inquiry is all about is simply ridiculous.
Sunday Dec 11th - London Times article - Woodford disgusted
Tuesday Dec 13th - NWBO claims to have received SEC inquiry
Thursday Dec 15th Investigator Liau comments on Plll. Pitches for $donors
Tuesday Dec 20th - NWBO in filing announces SEC inquiry
Perhaps. But given the timing of the London Times article and move to OTC, it should be material.
I stand corrected. You are right about it only being an inquiry. I guess Feuerstein got ahead of himself. It is an inquiry and could be sent to the next level, becoming an investigation. Either way, I'd bet Woodford is putting the heat on Powers. Timing of that London Times article is too close.
I'm rarely wrong but happy to admit when it happens.
I don't believe for a second the inquiry has to do with manipulation on the company's behalf. And if, by some crazy chance, it does then why not just say so instead of putting more pressure on the share price?
I'd give anything for a chance to work at the SEC and chase these bad penny stock players. I've been doing this investing thing for so long and have seen so much. Oh well.
LEGAL DEVELOPMENTS
On December 13, 2016, the Company received a formal information request from the SEC regarding several broad topics that have been previously disclosed, including the Company’s membership on Nasdaq and delisting, related party matters, and the Company’s special committee investigation. The period covered is January 1, 2013 to the present. The Company intends to cooperate fully.
S-22
So a full week went by without a peep to shareholders and maybe would've been longer if not for this offering. A material event withheld for a week!
I'd hope Woodford is behind this.
And does London based Woodford have anything to do with it now or in the future?
Thank you.
Yes, you've done well with that strategy over the last ten years. Feel like I always need to remind you people that many shareholders have lost nearly everything. With your strategy what to you stand to gain, a few percent in share price if the market sees "the information" just so? At least with my one question you'll know you've been taken to the cleaners, at be able to act for once.
But you could ask him if she likely can tell the difference between a donor and a shareholder, not be the later herself.
I've seen this all before; Try to convince poor shareholders not to ask the tough questions. I once attended a cc where management had hired a bunch of security to protect them from shareholders. That stock went down the toilet, of course.
Correct. There's many ways to ask it but it must be asked directly and with no wiggle room.
Have Shareholders lost almost their entire investment due to PhaseFive allegations being true and unchallenged or because the vaccine won't be commercialized in a timely manner?
Thank you.
So what. Ask the question and let them remain silent. There are no institutions left to ask it. What'd you have to lose?
A cash deal was just done so it's extremely unlikely any material news will come over the next thirty days. OTC is going to crush holders.
Expanded version: Can you assure shareholder here and now that the investigation is two prong; That both discovery into the allegations against CEO Powers herself, and into PhaseFive itself and its motivations, will be made available to shareholders?
Feuerstein knows this thing is criminal. End of story, unfortunately.
When Powers looked at Woodford I'd bet she saw a giant barrel chested kangaroo with a red ribbon on its head. What a disaster for him. What was he thinking?
Correct. And how about that PhaseFive investigating and clearing Powers name? ...Been so long I forget, were Black&Co. looking to do one or the other or both? Lol.
Just a little light on that subject would've gotten them a better price...Assuming lies were told, of course. Hmmm.
It's called taking advantage of retail holiday cheer. The bells, champagne, a toast to long-loyal determination paying off, and then the rug pull. You can all toast to Powers on the 23rd.
Lol.
Yes ask her that. Whatever you do don't ask about the investigation or the London Times article. Do not ask why the trial investigator is speaking about a blinded trial and affecting share price. Do not ask why Powers never holds q calls. And absolutely do not ask why she'd throw shareholders under the bus by moving to the OTC rather than simply partnering.
Only ask if it's possible she can get more money from tax payers.
Lol.
"As it has no minimum financial standards, the OTCQB includes shell companies, penny stocks and small foreign issuers."
Read more: OTCQB Definition | Investopedia http://www.investopedia.com/terms/o/otcqb.asp#ixzz4TLE3QR1c
Follow us: Investopedia on Facebook
Don't you know, friend, that's also a good thing!
I think it's entirely possible Powers&Co. will vanish, leaving this little pink sheet a shell priced @.001345, or there about. The trial relegated to some low level study recorded in some academic paper a year or more from now. You people still clinging on for any news, of course.
"Fact"... Yes that's why the share price continues to crumble, why the former Enron employee turned NW CEO never says a word and controls everything, why Black&Co. and the year-long alleged investigation turns from investigating the CEO's doings to investigating P5 allegations motivation, and turns up zero! why the Sunday London Times says Woodford is done with this thing, and Woodford himself so disgusted he's a no show for common shareholders, why they moved to the unscrupulous OTC, why the investigator tips off the public with zero response from the NWBO, why they can't seem to raise any cash, why...
Counter to claims made here, moving to the OTC/Pink allows for a more nebulous approach to SEC reporting and disseminating material news.
Ex, how can she be allowed to comment on an ongoing blinded trial?...You seriously don't see any infraction of the rules that prevent bias and proper disclosure?
Are you saying the supplier never billed the client?
Oh, they could very well, and now that they're on the OTC it won't be pretty. Have to wonder who are the OTC boys handling this baby?
So why not out them in a separate program away from the Plll?
Answer - Who'd pay for it?
Correct. It's over.
Does anyone here know how Cognant billed NW and what amount was cash vs. shares?
Thanks.
Absolutely. They likely know the fate of NW and probably shorted themselves in the Nasdaq. You do understand that if the short trade isn't executed properly the share price will artificially move up - Just like buying "at market" if buying long.
Yeah, that's not material information. I'm sure they'll get to it sooner or later. Lol. Oh please.
Give it a rest, Black is no hero. Shareholders have lost just about everything and now many forced to leave with move to OTC. Powers, Black, and the rest are a major let down, and now you're happy they hang around collecting fees. Pure craziness.
You just can't make this stuff up.
Yep, right again, it was a holiday retail trap.
Note to self: Nobody seems to care that the investigator is discussing a blinded study and not even mentioning the sponsor. Hmm.
...and who was it that posted on NovoCure weeks ago as it relates to SOP? Yes, me. And not one even replied...Probably got deleted. But I see Liau brought it up.
Sorry, Marzan, but Ex is totally right. It's how these little penny stock execs make nice salaries and bonuses...They pay to play. BP gets data and product exposure, academia gets studies paid, patients get the control, and maybe, just maybe, in some extreme long shot, something interesting in the combo that wasn't expected pops up.
In effect retail investors are nothing more than donors. Liau, with her chats, displays this perfectly.